Company intelligence / Profile preview

Jefferson Corner Group I

Charlottesville, Virginia, United States

Ownership: Private
Development stage: Other

Overview

Jefferson Corner Group I is a Charlottesville-based, member-managed angel fund that provides early-stage investment capital to University of Virginia (U.Va.) spin-off companies and other high-growth technology businesses. Administered by Spinner Technologies, a subsidiary of the U.Va. Patent Foundation, the fund focuses on commercializing innovations in the life sciences, biotechnology, and healthcare sectors. Its portfolio includes companies such as Neuronascent, PluroGen Therapeutics, and ADial Pharmaceuticals. The group aims to bridge the gap between academic research and the marketplace by providing both capital and strategic guidance to nascent startups.

Industry: Investors

Partnerships

University of Virginia Patent FoundationSpinner Technologies

Beyond the preview

Go deeper on Jefferson Corner Group I.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jefferson Corner Group I.

Explore the full profile